U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Regeneron Pharmaceuticals

Market Cap: US$59.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Thermo Fisher Scientific

Market Cap: US$176.7b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Precigen

Market Cap: US$1.2b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Exact Sciences

Market Cap: US$10.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

Danaher

Market Cap: US$133.1b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

BioCryst Pharmaceuticals

Market Cap: US$1.6b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Apogee Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Disc Medicine

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Incyte

Market Cap: US$16.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Stoke Therapeutics

Market Cap: US$1.3b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Akero Therapeutics

Market Cap: US$3.8b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Belite Bio

Market Cap: US$2.3b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

Insmed

Market Cap: US$29.8b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Cidara Therapeutics

Market Cap: US$2.2b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

89bio

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

NewAmsterdam Pharma

Market Cap: US$3.0b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Vera Therapeutics

Market Cap: US$1.7b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.

Xeris Biopharma Holdings

Market Cap: US$1.3b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

GRAIL

Market Cap: US$1.7b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

Xenon Pharmaceuticals

Market Cap: US$2.8b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Enliven Therapeutics

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Arrowhead Pharmaceuticals

Market Cap: US$4.5b

Develops medicines for the treatment of intractable diseases in the United States.

Azenta

Market Cap: US$1.4b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Bio-Techne

Market Cap: US$8.0b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Immunocore Holdings

Market Cap: US$1.7b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

Spyre Therapeutics

Market Cap: US$1.0b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Bruker

Market Cap: US$4.9b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Procaps Group

Market Cap: US$2.9b

Develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe.

Jazz Pharmaceuticals

Market Cap: US$7.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Elanco Animal Health

Market Cap: US$9.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Neurocrine Biosciences

Market Cap: US$14.5b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Supernus Pharmaceuticals

Market Cap: US$2.6b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Revvity

Market Cap: US$9.8b

Provides health sciences solutions, technologies, and services.

Vericel

Market Cap: US$1.5b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.